| Literature DB >> 29253859 |
Cheol Hwan So1, Hwal Rim Jeong2, Young Suk Shim2.
Abstract
OBJECTIVES: This study aimed to evaluate the association between sodium intake and metabolic syndrome (MetS) in Korean boys.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29253859 PMCID: PMC5734790 DOI: 10.1371/journal.pone.0189934
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flow chart of the study population.
In total, 1,738 Korean boys were included in the present study.
Clinical characteristic of the study participants according to the urinary sodium to urinary specific gravity ratio in Korean boys aged 10–18 years (n = 1,738).
| Urinary sodium to urinary specific gravity ratio (mmol/L) | |||||
|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | ||
| n = 434 | n = 435 | n = 435 | n = 434 | ||
| [<95.66] | [95.66–133.27] | [133.27–178.50] | [≥178.50] | ||
| Age (years) | 13.90 ± 0.12 | 13.73 ± 0.12 | 13.72 ± 0.12 | 13.82 ± 0.12 | 0.697 |
| Height SDS | 0.38 ± 0.05 | 0.52 ± 0.05 | 0.53 ± 0.05 | 0.47 ± 0.05 | 0.147 |
| Weight SDS | 0.02 ± 0.05 | 0.16 ± 0.05 | 0.28 ± 0.05 | 0.38 ± 0.06 | <0.001 |
| BMI SDS | -0.19 ± 0.05 | -0.08 ± 0.05 | 0.04 ± 0.05 | 0.21 ± 0.05 | <0.001 |
| WC SDS | -0.44 ± 0.05 | -0.31 ± 0.05 | -0.19 ± 0.05 | -0.01 ± 0.06 | <0.001 |
| SBP (mmHg) | 106.93 ± 0.51 | 107.57 ± 0.59 | 107.49 ± 0.52 | 109.33 ± 0.54 | 0.011 |
| DBP (mmHg) | 66.77 ± 0.47 | 66.83 ± 0.47 | 66.32 ± 0.46 | 67.87 ± 0.46 | 0.013 |
| Glucose (mg/dL) | 89.16 ± 0.30 | 89.45 ± 0.31 | 90.04 ± 0.27 | 90.64 ± 0.31 | 0.003 |
| T-C (mg/dL) | 151.83 ± 1.23 | 157.11 ± 1.36 | 154.24 ± 1.24 | 155.93 ± 1.53 | 0.034 |
| HDL-C (mg/dL) | 53.26 ± 0.50 | 54.24 ± 0.52 | 52.98 ± 0.51 | 51.58 ± 0.49 | 0.003 |
| TG (mg/dL) | 75.87 ± 1.96 | 80.60 ± 2.21 | 85.31 ± 2.54 | 93.46 ± 3.20 | <0.001 |
| LDL-C (mg/dL) | 83.40 ± 1.03 | 86.75 ± 1.16 | 84.39 ± 1.07 | 86.23 ± 1.37 | 0.145 |
| Ferritin (ng/mL) | 53.44 ± 1.91 | 51.00 ± 1.64 | 48.84 ± 1.40 | 45.94 ± 1.56 | 0.010 |
| Vitamin D (ng/mL) | 17.88 ± 0.29 | 17.93 ± 0.27 | 18.30 ± 0.28 | 17.92 ± 0.26 | 0.672 |
| Urinary specific gravity (mmol/L) | 1.02 ± 0.00 | 1.02 ± 0.00 | 1.02 ± 0.00 | 1.02 ± 0.00 | <0.001 |
| Urinary sodium (mmol/L) | 70.94 ± 0.93 | 117.92 ± 0.55 | 159.18 ± 0.64 | 224.43 ± 1.87 | <0.001 |
| Urinary sodium to urinary specific gravity ratio | 69.50 ± 0.90 | 115.27 ± 0.54 | 155.44 ± 0.62 | 219.26 ± 1.83 | <0.001 |
| Season | 0.576 | ||||
| Spring | 84 (19.4%) | 96 (22.1%) | 78 (17.9%) | 72 (16.6%) | |
| Summer | 118 (27.2%) | 115 (26.4%) | 109 (25.1%) | 121 (27.9%) | |
| Autumn | 110 (25.3%) | 105 (24.1%) | 120 (27.6%) | 126 (29.0%) | |
| Winter | 122 (28.1%) | 119 (27.4%) | 128 (29.4%) | 115 (26.5%) | |
| House income ≤lowest quartile (%) | 39 (9.0%) | 54 (12.4%) | 45 (10.3%) | 72 (16.6%) | 0.004 |
| Smoking (%) | 41 (9.4%) | 34 (7.8%) | 38 (8.7%) | 43 (9.9%) | 0.723 |
| Alcohol intake (%) | 44 (10.1%) | 42 (9.7%) | 41 (9.4%) | 42 (9.7%) | 0.988 |
| Physical activity (%) | 272 (62.7%) | 277 (63.7%) | 276 (63.4%) | 296 (68.2%) | 0.312 |
| Total intake (g/day) | 1455.72 ± 33.66 | 1453.13 ± 30.85 | 1412.77 ± 31.97 | 1400.72 ± 34.32 | 0.533 |
| Total energy intake (kcal/day) | 2275.36 ± 43.76 | 2283.16 ± 42.33 | 2288.13 ± 43.19 | 2282.06 ± 47.83 | 0.998 |
| Protein intake (g/day) | 81.27 ± 2.24 | 81.30 ± 1.92 | 83.13 ± 1.94 | 81.67 ± 2.01 | 0.907 |
| Fat intake (g/day) | 57.90 ± 1.96 | 57.22 ± 1.65 | 60.68 ± 2.07 | 56.70 ± 1.75 | 0.445 |
| Carbohydrate intake (g/day) | 355.57 ± 6.26 | 359.72 ± 6.65 | 352.24 ± 6.15 | 357.28 ± 7.34 | 0.879 |
| Sodium intake (g/day) | 4.82 ± 0.12 | 4.36 ± 0.11 | 4.74 ± 0.13 | 4.70 ± 0.15 | 0.016 |
| Water intake (g/day) | 933.21 ± 26.48 | 932.37 ± 24.29 | 890.92 ± 25.09 | 878.89 ± 26.68 | 0.309 |
The data are shown as the means ± SEs (standard errors).
BMI; body mass index, SDS; standard deviation score, WC; waist circumference, SBP; systolic blood pressure, DBP; diastolic blood pressure, HOMA-IR; homeostatic model assessment of insulin resistance, QUICKI; quantitative insulin sensitivity check index, T-C; total cholesterol, HDL-C; high-density lipoprotein cholesterol, TG; triglyceride, LDL-C; low-density lipoprotein cholesterol.
Adjusted means for metabolic syndrome (MetS) components according to the urinary sodium to urinary specific gravity ratio in Korean boys aged 10–18 years (n = 1,738).
| Urinary sodium to urinary specific gravity ratio | |||||
|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | ||
| WC SDS | -0.30 ± 0.02 | -0.25 ± 0.02 | -0.25 ± 0.02 | -0.22 ± 0.02 | 0.173 |
| SBP (mmHg) | 106.95 ± 0.50 | 107.72 ± 0.50 | 107.47 ± 0.51 | 108.76 ± 0.51 | 0.086 |
| DBP (mmHg) | 66.15 ± 0.45 | 66.93 ± 0.44 | 66.26 ± 0.45 | 67.69 ± 0.46 | 0.063 |
| Glucose (mg/dL) | 89.56 ± 0.31 | 89.67 ± 0.30 | 90.12 ± 0.31 | 90.55 ± 0.32 | 0.099 |
| HDL-C (mg/dL) | 53.11 ± 0.52 | 54.29 ± 0.51 | 52.98 ± 0.53 | 52.14 ± 0.53 | 0.033 |
| TG (mg/dL) | 77.89 ± 2.66 | 82.23 ± 2.63 | 85.29 ± 2.71 | 92.79 ± 2.72 | 0.001 |
The data are shown as the means ± SEs (standard errors).
WC; waist circumference, SDS; standard deviation score, SBP; systolic blood pressure, DBP; diastolic blood pressure, HDL-C; high-density lipoprotein cholesterol, TG; triglyceride.
Adjusted means for WC SDS, SBP, DBP, glucose, HDL-C, and TG were determined after adjustment for age, body mass index (BMI) SDS, ferritin, vitamin D, house income, smoking, alcohol intake, physical activity, season, total intake, total energy intake, protein intake, fat intake, carbohydrate intake, sodium intake, and water intake through an analysis of covariance (ANCOVA) according to the urinary sodium to urinary specific gravity ratio.
a: P<0.05 vs. the first quartile
b: P<0.05 vs. the second quartile
c: P<0.05 vs. the third quartile.
Adjusted odds ratio (95% CI) of metabolic syndrome (MetS) and its components according to the urinary sodium to urinary specific gravity ratio in Korean boys aged 10–18 years (n = 1,738).
| Urinary sodium to urinary specific gravity ratio | |||||
|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | ||
| Elevated WC | Reference | 0.97 (0.38–2.45) | 0.35 (0.13–0.94) | 0.72 (0.29–1.78) | 0.249 |
| Elevated BP | Reference | 1.10 (0.79–1.52) | 0.87 (0.62–1.22) | 1.27 (0.91–1.76) | 0.352 |
| Elevated glucose | Reference | 1.01 (0.13–7.58) | 0.79 (0.10–5.99) | 1.38 (0.23–8.43) | 0.741 |
| Reduced HDL-C | Reference | 0.97 (0.57–1.65) | 1.18 (0.70–1.99) | 1.32 (0.79–2.21) | 0.209 |
| Elevated TG | Reference | 1.34 (0.92–1.95) | 1.44 (0.99–2.10) | 1.73 (1.19–2.51) | 0.004 |
| MetS | Reference | 1.74 (0.68–4.42) | 1.28 (0.49–3.34) | 2.66 (1.11–6.35) | 0.039 |
WC, waist circumference; BP, blood pressure; HDL-C, high-density lipoprotein cholesterol; TG, triglyceride, MetS; metabolic syndrome.
The adjusted odds ratios (ORs) of MetS and its components were calculated through multivariate logistic regression analyses after adjustment for age, body mass index (BMI) standard deviation scores (SDS), ferritin, vitamin D, house income, smoking, alcohol intake, physical activity, season, total intake, total energy intake, protein intake, fat intake, carbohydrate intake, sodium intake, and water intake.
Elevated WC was defined as values greater than or equal to the 90th percentile for age and gender. Elevated BP was defined as SBP or DBP greater than or equal to the 90th percentile for age, gender, and height or current administration of antihypertensive drug. Elevated glucose was defined as glucose greater than or equal to 110 mg/dL or medication for diabetes. Elevated TG was defined as TG greater than or equal to 110 mg/dL or current administration of drugs for dyslipidemia. Reduced HDL-C was defined as HDL-C less than 40 mg/dL or current administration of drugs for dyslipidemia.